Azelastine Allergen Chamber - Onset of Action Study

Conditions: Seasonal Allergic Rhinitis Interventions: Drug: Treatment A: Azelastine hydrochloride 0.15% nasal spray (Azelair); Drug: Treatment B: Placebo (Azelastine 0.15% vehicle) nasal spray; Drug: Treatment C: Ryaltris (Active Control) - mometasone furoate monohydrate and olopatadine hydrochloride nasal spray Sponsors: MEDA Pharma GmbH& Co. KG Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials